Physician

Pankaj J Patel, M.D.

According to 2025 Medicare claims, Pankaj Patel, M.D. (NPI: 1124009766) practices pulmonary disease in the Midland, TX market, with the plurality of this provider's patient population coming from Midland, TX. Patel uses personal NPI as billing NPI and primary practice location at 79703-5132. Patel is affiliated with the The Accountable Care Organization, Ltd. (ACO ID: A2098) and CoreHealth Alliance LLC (ACO ID: A5645), participating under the MSSP model.

Patel's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 686 traditional Medicare patients, billed 2,773 HCPCS/CPT codes, and received $164,073 in Medicare payments. The top billing code was 99204 (New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more). Part D data shows 7,734 prescription claims across 785 beneficiaries totaling $2,208,328 in drug costs, led by Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter). DME data shows 2,565 claims. Open Payments data shows 17 records totaling $407. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has declined steadily, from $246,757 to $164,073. In contrast, Part D prescription costs have risen steadily, from $1,660,019 to $2,208,328. For DME billing, reported payments moved up and down with repeated peaks and valleys, starting at $298,661 and ending at $177,384.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,129	5,967	$246,757
2016	1,109	5,791	$243,711
2017	1,075	5,068	$235,052
2018	965	4,109	$199,382
2019	860	4,158	$208,108
2020	690	2,707	$134,407
2021	711	2,871	$171,951
2022	729	2,920	$166,133
2023	686	2,856	$161,066
2024	686	2,773	$164,073

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	1,022	14,256	$1,660,019
2016	944	13,134	$1,602,936
2017	942	11,490	$1,640,051
2018	850	10,400	$1,723,273
2019	825	9,729	$1,662,372
2020	711	8,375	$1,571,221
2021	732	8,413	$1,922,822
2022	741	8,238	$2,081,266
2023	748	7,480	$2,420,527
2024	785	7,734	$2,208,328

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	678	3,119	$297,283
2016	619	3,068	$202,856
2017	639	2,991	$148,237
2018	603	2,401	$120,542
2019	551	2,513	$129,411
2020	573	2,278	$155,768
2021	457	1,997	$173,943
2022	524	2,163	$193,973
2023	543	2,593	$237,896
2024	558	2,565	$175,873

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	109	109	$109
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	340	646	$84
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	468	835	$56
94060	Test to measure expiratory airflow and volume changes before and after medication administration	126	131	$8
94729	Test to examine how well the lungs exchange gases	95	99	$7

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	149	9,390	$195,182
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	144	9,060	$184,681
Ofev	Nintedanib Esylate	12	360	$179,019
Letairis	Ambrisentan	13	390	$168,747
Spiriva Respimat	Tiotropium Bromide	136	7,772	$130,870

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	128	902	$71,234
E0466	Home ventilator, any type, used with non-invasive interface, (e.g., mask, chest shell)	Y	N/R	33	$45,335
E1392	Portable oxygen concentrator, rental	Y	67	476	$16,195
A7031	Face mask interface, replacement for full face mask, each	N	23	60	$5,857
A7030	Full face mask used with positive airway pressure device, each	N	26	60	$5,582

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	17	$407	AstraZeneca Pharmaceuticals LP
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Pankaj J. Patel, M.D.?

Tedicare shows public-source Medicare data for Pankaj J. Patel, M.D. (NPI 1124009766), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Pankaj J. Patel, M.D. have ACO affiliation data?

Pankaj J. Patel, M.D. is shown with ACO affiliation data for The Accountable Care Organization, Ltd. (MSSP, ACO ID A2098) and CoreHealth Alliance LLC (MSSP, ACO ID A5645).

What billing organization is linked to Pankaj J. Patel, M.D.?

A separate primary affiliated billing organization is not shown for this profile in the available data.

Does Pankaj J. Patel, M.D. have Open Payments data?

Pankaj J. Patel, M.D. has 17 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.